FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W804575795> ?p ?o ?g. }

• W804575795 endingPage "2549" @default.
• W804575795 startingPage "2549" @default.
• W804575795 abstract "Abstract The PIM family of serine/threonine kinases (PIM1, PIM2, PIM3) are important regulators of signal transduction that phosphorylate proteins essential for cell proliferation, survival, and apoptosis. The PIM kinases are constitutively active and broadly expressed in multiple tissues and up-regulated in various malignancies. We report the discovery of a novel fusion transcript encoding the kinase domain of PIM3 fused to SCO2, a cytochrome c oxidase assembly protein. In transcript sequencing (RNA Seq) of 68 pediatric AML cases, PIM3-SCO2 fusion transcript was computationally identified and experimentally verified in index cases and studied in an independent cohort of pediatric patients with AML. RNA-Seq performed on the Illumina HiSeq in 68 diagnostic specimens from children with AML treated on COG clinical trials. Sequence reads were mapped to human genome using Novoalign. Four computational methods including Defuse, TophatFusion, FusionMap, and Snowshoes-FTD, were utilized to identify fusion transcripts and after filtering to eliminate false positives, fusions were selected based on observation in 2 or more fusion methods and presence in chimerDB. PIM3-SCO2 was identified as an in-frame fusion transcript in 3 cases with Inv(16) and subsequently verified by RT-PCR and Sanger sequencing. Frequency validation was performed by semi-quantitative expression analysis of PIM3-SCO2 expression levels in 235 AML diagnostic specimens as well as 6 normal bone marrow (NBM) controls. PIM3-SCO2 fusion protein was assessed by Western blot on whole cell lysates from cases with the fusion transcript. After verification of the fusion, available whole genome sequencing data in matching cases was interrogated and failed to demonstrate genomic counterpart to this fusion transcript, suggesting that this fusion may be the result of transcriptional read-through; also called transcription-induced chimera (TIC). Such fusion transcripts are generated when genes in proximity on a genome strand are spliced together to generate a chimeric product. Frequency validation studies in 235 diagnostic specimens from COG AAML0531 demonstrated that PIM3-SCO2 fusion transcript was highly prevalent in AML and expressed in 187 of the 235 cases of AML (80%) with variable prevalence across different cytogenetic cohorts, with prevalence of 87% in CBF, 56% in MLL, 79% in normal karyotype, and 70% in those with “other” karyotypes (p<0.001) Further evaluation of the expression level of the fusion product demonstrated significant variability among AML patients. Given the high prevalence of fusion transcript in AML specimens, we evaluated the expression of PIM3-SCO2 transcript in normal marrow as well as in non-hematopoietic tissues. PIM3-SCO2 fusion was detected at low levels in whole normal marrow, but was absent in T cells as well non-hematopoietic tissues including cerebellum, cortex, thymus, skeletal muscle, and tongue. Protein lysates from various tissues and in patients with PIM3-SCO2 fusions was interrogated for the presence of PIM3 protein variant using an antibody directed at the amino terminal end of PIM3 protein. Normal PIM3 protein of 36 kDa was detected in HEK-293 kidney derived cell line and in Jurkat cells; however, in patient specimens with the fusion transcript, presence of a 50 kDa protein, which is the expected protein product of the fusion transcript, was confirmed. Although the appropriate PIM3 protein product was observed in non hematopoietic tissues, only the fusion product was observed in hematopoietic cells, including normal marrow, suggesting that the fusion product may be the only translated product of PIM3 in normal hematopoiesis. Gene expression profiling of 226 Dx and 35 relapse samples was performed. Compared to normal marrow, PIM3 exhibited significantly higher expression at diagnosis (p=0.04) and at relapse (p=0.022). In addition, PIM3 related signaling genes were also overrepresented on pathway analysis in Dx and Relapse samples vs. normal bone marrow. Our data show that a novel PIM3-SCO2 fusion transcript, which is likely a transcription-induced chimera of the two gene transcripts, may be involved in normal hematopoietic development whose expression is highly dysregulated in AML. Expression level of this chimeric product is highly variable in childhood AML, is associated with cytogenetic and molecular subsets, and may identify a potential target for therapeutic intervention. Disclosures: No relevant conflicts of interest to declare." @default.
• W804575795 created "2016-06-24" @default.
• W804575795 creator A5004976895 @default.
• W804575795 creator A5008106632 @default.
• W804575795 creator A5010523212 @default.
• W804575795 creator A5014498991 @default.
• W804575795 creator A5017522276 @default.
• W804575795 creator A5026631504 @default.
• W804575795 creator A5046943976 @default.
• W804575795 creator A5049490094 @default.
• W804575795 creator A5051368343 @default.
• W804575795 creator A5055685996 @default.
• W804575795 creator A5066861312 @default.
• W804575795 creator A5072186290 @default.
• W804575795 creator A5073322914 @default.
• W804575795 creator A5081841674 @default.
• W804575795 creator A5081942700 @default.
• W804575795 creator A5082967648 @default.
• W804575795 date "2013-11-15" @default.
• W804575795 modified "2023-10-03" @default.
• W804575795 title "PIM3-SCO2 Fusion Is a Novel Transcription-Induced Chimera That Is Highly Prevalent In Childhood AML" @default.
• W804575795 doi "https://doi.org/10.1182/blood.v122.21.2549.2549" @default.
• W804575795 hasPublicationYear "2013" @default.
• W804575795 type Work @default.
• W804575795 sameAs 804575795 @default.
• W804575795 citedByCount "3" @default.
• W804575795 countsByYear W8045757952022 @default.
• W804575795 countsByYear W8045757952023 @default.
• W804575795 crossrefType "journal-article" @default.
• W804575795 hasAuthorship W804575795A5004976895 @default.
• W804575795 hasAuthorship W804575795A5008106632 @default.
• W804575795 hasAuthorship W804575795A5010523212 @default.
• W804575795 hasAuthorship W804575795A5014498991 @default.
• W804575795 hasAuthorship W804575795A5017522276 @default.
• W804575795 hasAuthorship W804575795A5026631504 @default.
• W804575795 hasAuthorship W804575795A5046943976 @default.
• W804575795 hasAuthorship W804575795A5049490094 @default.
• W804575795 hasAuthorship W804575795A5051368343 @default.
• W804575795 hasAuthorship W804575795A5055685996 @default.
• W804575795 hasAuthorship W804575795A5066861312 @default.
• W804575795 hasAuthorship W804575795A5072186290 @default.
• W804575795 hasAuthorship W804575795A5073322914 @default.
• W804575795 hasAuthorship W804575795A5081841674 @default.
• W804575795 hasAuthorship W804575795A5081942700 @default.
• W804575795 hasAuthorship W804575795A5082967648 @default.
• W804575795 hasConcept C104317684 @default.
• W804575795 hasConcept C111829193 @default.
• W804575795 hasConcept C11960822 @default.
• W804575795 hasConcept C123894998 @default.
• W804575795 hasConcept C138885662 @default.
• W804575795 hasConcept C179926584 @default.
• W804575795 hasConcept C184235292 @default.
• W804575795 hasConcept C2776414213 @default.
• W804575795 hasConcept C2778274637 @default.
• W804575795 hasConcept C40767141 @default.
• W804575795 hasConcept C41895202 @default.
• W804575795 hasConcept C51679486 @default.
• W804575795 hasConcept C54355233 @default.
• W804575795 hasConcept C70721500 @default.
• W804575795 hasConcept C76818968 @default.
• W804575795 hasConcept C86803240 @default.
• W804575795 hasConcept C98175054 @default.
• W804575795 hasConceptScore W804575795C104317684 @default.
• W804575795 hasConceptScore W804575795C111829193 @default.
• W804575795 hasConceptScore W804575795C11960822 @default.
• W804575795 hasConceptScore W804575795C123894998 @default.
• W804575795 hasConceptScore W804575795C138885662 @default.
• W804575795 hasConceptScore W804575795C179926584 @default.
• W804575795 hasConceptScore W804575795C184235292 @default.
• W804575795 hasConceptScore W804575795C2776414213 @default.
• W804575795 hasConceptScore W804575795C2778274637 @default.
• W804575795 hasConceptScore W804575795C40767141 @default.
• W804575795 hasConceptScore W804575795C41895202 @default.
• W804575795 hasConceptScore W804575795C51679486 @default.
• W804575795 hasConceptScore W804575795C54355233 @default.
• W804575795 hasConceptScore W804575795C70721500 @default.
• W804575795 hasConceptScore W804575795C76818968 @default.
• W804575795 hasConceptScore W804575795C86803240 @default.
• W804575795 hasConceptScore W804575795C98175054 @default.
• W804575795 hasIssue "21" @default.
• W804575795 hasLocation W8045757951 @default.
• W804575795 hasOpenAccess W804575795 @default.
• W804575795 hasPrimaryLocation W8045757951 @default.
• W804575795 hasRelatedWork W1915589771 @default.
• W804575795 hasRelatedWork W1967115478 @default.
• W804575795 hasRelatedWork W1977449656 @default.
• W804575795 hasRelatedWork W1990145453 @default.
• W804575795 hasRelatedWork W2011586448 @default.
• W804575795 hasRelatedWork W2340925765 @default.
• W804575795 hasRelatedWork W2587686721 @default.
• W804575795 hasRelatedWork W3049015638 @default.
• W804575795 hasRelatedWork W3087062922 @default.
• W804575795 hasRelatedWork W804575795 @default.
• W804575795 hasVolume "122" @default.
• W804575795 isParatext "false" @default.
• W804575795 isRetracted "false" @default.
• W804575795 magId "804575795" @default.
• W804575795 workType "article" @default.